Innovation and Growth Strategies at Hologic/Cytyc/Novasure

Hi,

I am an MBA student and am doing a project on innovation and growth for GEA and more specifically Novasure.

Anyone have any insight into how Hologic innovation process works? What do they do to keep their R&D pipeline full? Do they have dedicated people who work on new product ideas? How do they incent this behavior (bonus, IP blood money, keep you employed?). Do they foster new ideas or do they just flush them out and let them die on dusty lab shelf?

Is there a set process? Is it well funded?

Any details however vague would be appreciate. Thanks for your help.

Originally Posted by Anonymous

Hi,

I am an MBA student and am doing a project on innovation and growth for GEA and more specifically Novasure.

Anyone have any insight into how Hologic innovation process works? What do they do to keep their R&D pipeline full? Do they have dedicated people who work on new product ideas? How do they incent this behavior (bonus, IP blood money, keep you employed?). Do they foster new ideas or do they just flush them out and let them die on dusty lab shelf?

Is there a set process? Is it well funded?

Any details however vague would be appreciate. Thanks for your help.

Good luck getting an answer to this. Most of us Novasure reps wonder ourselves what R&D does back there. Keep getting promised new products and Novasure improvements that never come.